Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
BackgroundGliomas are the most common intracranial malignant tumors. In this study, we aimed to identify the hub genes and investigate the pathophysiological significance of ANXA5 in glioma.MethodsThe differentially expressed genes (DEGs) between tumor and adjacent tissues from glioma patients were...
Saved in:
| Main Authors: | WeiXian Liu, Tao Xiong, Hu Sun, Ming Wang, JunGao Zhu, ChuanChuan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1550961/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics
by: Hongyu Wang, et al.
Published: (2025-01-01) -
Prognostic Value of SERPINA1 as a Biomarker for Poor Survival of Gliomas
by: Nai-Jui Cheng, et al.
Published: (2025-07-01) -
Assessment of Immuno-histochemical Expression of CD44 in Renal Tumors
by: Banan Mohammed, et al.
Published: (2025-01-01) -
CD44 mediates the internalization of foot-and-mouth disease virus through macropinocytosis
by: Xuefei Wang, et al.
Published: (2025-06-01) -
Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma
by: Erin E. Crotty, et al.
Published: (2025-02-01)